SCHEMBL6169070

SCHEMBL6169070

CCCCN1C(=O)C(C)(c2ccc(OCc3ccccc3)cc2)NC1=S

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.50
ALDH1A1 P00352 3/20 0.48
GAA P10253 1/20 0.48
CNR1 P21554 3/20 0.47
MMP2 P08253 1/20 0.47
MMP13 P45452 1/20 0.47
SIRT2 Q8IXJ6 3/20 0.45
SIRT1 Q96EB6 3/20 0.45
SIRT5 Q9NXA8 3/20 0.45
PDE2A O00408 3/20 0.44
AR P10275 1/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
SIRT3 Q9NTG7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168238 0.78 NPC1 (0.51) ALDH1A1GAAMMP2MMP13SIRT2
SCHEMBL6168135 0.77 LMNA (0.49) ALDH1A1GAAMMP2MMP13SIRT2
SCHEMBL6167465 0.76 L3MBTL1 (0.47) ALDH1A1GAACNR1MMP2MMP13
SCHEMBL6168721 0.75 CNR1 (0.54) ALDH1A1GAACNR1MMP2MMP13
SCHEMBL7486579 0.72 CNR1 (0.59) FAAHALDH1A1GAACNR1LMNA
SCHEMBL9233657 0.70 MMP13 (0.71) ALDH1A1MMP2MMP13LMNA
SCHEMBL542696 0.70 MMP13 (0.71) ALDH1A1MMP2MMP13LMNA
SCHEMBL6169138 0.69 CNR1 (0.49) ALDH1A1GAACNR1MMP2MMP13
SCHEMBL5954451 0.69 MEN1 (0.44) ALDH1A1SIRT2SIRT1SIRT5PDE2A
SCHEMBL9893251 0.69 KCNA5 (0.51) AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546111-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2005-06-29 EP disclosed
WO-2004031160-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2004-04-15 WO disclosed